Welcome to allnurses: A Nursing Community for Nurses
The largest most active online nursing community. Join 312,348 nurses from around the world to learn, communicate, and network. For full allnurses.com access, register today - it's free! Problems during registration? Please don't hesitate to contact support.
Participate in over 200 nursing forums and browse over 2.6 million posts.
The FDA and its Canadian counterpart began reviewing the drugs, used by tens of millions of people, back in May. The drug's manufacturer, AstraZeneca PLC, provided an early analysis of two small studies that suggested the possibility of a risk. The agency said its review of that study as well as 14 others indicated no increased risk for patients.